期刊文献+

药物的跨膜转运机制研究进展 被引量:11

Research progress on drug transmembrane transport mechanism
原文传递
导出
摘要 机体的最基本单位为细胞,药物的体内动态就是其在体内一系列跨膜转运的综合效果,因此掌握药物跨膜转运的特点和机制非常重要。以往在研究药物的跨膜过程时,多通过其理化性质来分析其跨膜能力。药物的理化性质并不是决定其跨膜能力的唯一因素,生物膜上的蛋白质在其跨膜过程中也起到了重要的、甚至是决定性的作用。主要就细胞膜的结构特点、跨膜转运机制及膜上的主要蛋白进行综述。 Cells are the most basic units of organism. Drugs' in vivo dynamics are a series of trans-membrane transport in the body of the combined effect, so to master the characteristics and mechanisms of drug transmembrane transport is very important. In the past, when studying the transmembrane process of drugs, most of them analyzed their physical and chemical properties to analyze the transmembrane capabilities. Recent studies have found that the physicochemical properties of drugs are not the only determinants of their transmembrane capacity, and proteins on biomembranes also play an important, even decisive, role in their transmembrane processes. In this paper, the structural characteristics of the cell membrane, transmembrane transport mechanism, and membrane protein are reviewed.
作者 慈小燕 崔涛 武卫党 谷元 伊秀林 CI Xiaoyan;CUI Tao;WU Weidang;GU Yuan;YI Xiulin(State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research New Drug Assessment Co.Ltd.,Tianjin 300193,China;Tianjin University of Traditional Chinese Medicine,Tianjin 300193,China)
出处 《药物评价研究》 CAS 2018年第6期973-979,共7页 Drug Evaluation Research
基金 国家自然科学基金青年科学基金项目(81503154)
关键词 跨膜转运机制 被动转运 转运体介导的跨膜转运 溶质转运体(SLC) ATP结合盒(ABC)转运体 transmembrane transport mechanism passive diffusion transporter-mediated transmembrane transport solute carrier(SLC) ATP binding cassette (ABC)
  • 相关文献

参考文献5

二级参考文献28

  • 1尤海生,张海凤,董亚琳,陈思颖,王茂义,董卫华,邢建峰.野黄芩苷和野黄芩素在Caco-2细胞模型中的吸收转运特性[J].中西医结合学报,2010,8(9):863-869. 被引量:12
  • 2贺敏,黄仁彬,刘曦.利福平对细胞色素P_(450)超家族及其相关药物的作用[J].中国药房,2006,17(21):1664-1666. 被引量:15
  • 3Shin-ichi Akiyama,Antonio Fojo,John A. Hanover,Ira Pastan,Michael M. Gottesman.Isolation and genetic characterization of human KB cell lines resistant to multiple drugs[J]. Somatic Cell and Molecular Genetics . 1985 (2)
  • 4FDA.Guidance for Industry:Drug interaction studies-study design,data analysis,and implications for dosing and labeling. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guida nces/ucm072101.pdf . 2006
  • 5Kanai Y,Fukasawa Y,et al.Transport properties of a system y+L neutral and basic amino acid transporter. Biological Chemistry . 2000
  • 6Sweet D H.Organic anion transporter(Slc22a)family members as mediators of toxicity. Toxicology and Applied Pharmacology . 2005
  • 7Robertson,EE,Rankin,GO.Human renal organic anion transporters: Characteristics and contributions to drug and drug metabolite excretion. Pharmacology and Therapeutics . 2006
  • 8Wright,S. H.Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics. Toxicology and Applied Pharmacology . 2005
  • 9Anzai N,Kanai Y,Endou H.Organic anion transporter family:current knowledge. Journal of Pharmacological Sciences . 2006
  • 10Nawashiro,H,Otani,N,Shinomiya,N.L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. International Journal of Cancer . 2006

共引文献34

同被引文献155

引证文献11

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部